This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jung, B. Articles by Ahmad, N. Search for Related Content PubMed PubMed Citation Articles by Jung, B. Articles by Ahmad, N. Related Collections Epidemiology and Prevention Epidemiology and Prevention: Chemoprevention

Melatonin in Cancer Management: Progress and Promise

¹ Department of Dermatology, ² Molecular and Environmental Toxicology Center, and ³ University of Wisconsin Comprehensive Cancer Center, University of Wisconsin, Madison, Wisconsin

Requests for reprints: Nihal Ahmad, Department of Dermatology, University of Wisconsin, Medical Science Center, 1300 University Avenue, Madison, WI 53706. Phone: 608-263-5359; Fax: 608-263-5223; E-mail: nahmad{at}wisc.edu.

Physiologic and pharmacologic concentrations of the pineal hormone melatonin have shown chemopreventive, oncostatic, and tumor inhibitory effects in a variety of in vitro and in vivo experimental models of neoplasia. Multiple mechanisms have been suggested for the biological effects of melatonin. Not only does melatonin seem to control development alone but also has the potential to increase the efficacy and decrease the side effects of chemotherapy when used in adjuvant settings. This review critically evaluates progress in the ability of melatonin to prevent or reverse cancer development and progression. We also discuss future prospects of the possible development of melatonin as a chemopreventive agent. (Cancer Res 2006; 66(20): 9789-93)

This article has been cited by other articles:

				K. DANIELCZYK and P. DZIEGIEL The Expression of MT1 Melatonin Receptor and Ki-67 Antigen in Melanoma Malignum Anticancer Res, October 1, 2009; 29(10): 3887 - 3895. [Abstract] [Full Text] [PDF]

				B. Jung-Hynes and N. Ahmad SIRT1 controls circadian clock circuitry and promotes cell survival: a connection with age-related neoplasms FASEB J, September 1, 2009; 23(9): 2803 - 2809. [Abstract] [Full Text] [PDF]